SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

835

Alere

ALR

Looking for leads, investment insights, or competitive intelligence?

CEO

Namal Nawana

CEO Title

President, Chief Executive Officer & Director

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Waltham, MA

Years on Fortune 500 List

-

Employees

9,200

Figures are for the four quarters ended Sept. 30, 2016.Profile provided by S&P Global.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$2,395-3.1%
Profits ($M)$-39.3-119.1%
Assets ($M)$5,856
Total Stockholder Equity ($M)$2,045.7
Market Value — as of March 31, 2017 ($M)$3,457
Profit Ratios
Profit as % of Revenues-1.6%
Profits as % of Assets-0.7%
Profits as % of Stockholder Equity-1.9%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)-0.73
EPS % Change (from 2015)-133.6%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2016)-0.3%
Total Return to Investors (5 year, annualized)11.0%
Total Return to Investors (10 year, annualized)0.1%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Alere

Abbott Finally Agrees to Buy Alere After Cutting the Price to $4.5 Billion

The firms have been fighting about the merger since it was announced in February 2016.

Read More →
This Blood-Testing Company Could Be the New Theranos

It also has parallels to Valeant—and not in a good way.

Read More →
Abbott Labs Has Officially Moved to Kill Its Deal to Buy Alere

But Alere says that none of the arguments made by Abbott give it grounds to abandon the merger.

Read More →
Alere Is Suing to Force Abbott to Complete Their $5.8 Billion Merger

Alere has received Department of Justice subpoenas this year as part of two separate investigations.

Read More →